Fresenius Medical Care revenue and financials
In the fiscal year ended December 2025, Fresenius Medical Care reported revenue of €19.63B (+1.51% year over year). Net income was €978.37M, a net margin of 5.0%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +1.51%
- 2025 vs 2024
- Net income growth
- +81.88%
- 2025 vs 2024
- Net margin
- 5.0%
- 2024: 2.8%
How Fresenius Medical Care is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 1.9% a year on average over the last 5 years
Compound annual growth rate: from €17.86B in 2020 to €19.63B in 2025.
Operating margin rose from 7.9% to 9.5%
Operating income over revenue, 2022 → 2025: 1.6 percentage points.
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 19,628 | 19,336 | 19,454 | 19,398 | 17,619 | 17,859 | 17,477 | 16,547 | 17,784 | 16,570 |
| Cost of revenue | 14,599 | 14,579 | 14,529 | 14,504 | 12,846 | 12,322 | 12,081 | 11,392 | 11,765 | 10,954 |
| Gross profit | 5,029 | 4,757 | 4,925 | 4,894 | 4,773 | 5,537 | 5,396 | 5,155 | 6,018 | 5,616 |
| Selling, general and administrative | 3,033 | 3,143 | 3,196 | 3,170 | 2,773 | 2,966 | 2,944 | 2,857 | 3,640 | 3,133 |
| Research and development | 158 | 183 | 232 | 229 | 221 | 194 | 168 | 114 | 111 | 147 |
| Operating income | 1,870 | 1,539 | 1,524 | 1,538 | 1,904 | 2,378 | 2,284 | 2,184 | 2,267 | 2,337 |
| EBIT | 1,870 | 1,539 | 1,524 | 1,538 | 1,904 | 2,378 | 2,284 | 2,184 | 2,267 | 2,337 |
| EBITDA | 2,622 | 2,347 | 2,436 | 2,512 | 2,799 | 3,261 | 3,137 | 2,909 | 3,002 | 3,038 |
| Interest expense | 384 | 407 | 425 | 360 | 354 | 410 | 491 | 448 | 416 | 427 |
| Pre-tax income | 1,512 | 1,057 | 1,033 | 1,219 | 1,572 | 1,936 | 1,840 | 2,737 | 1,998 | 2,045 |
| Income tax | 321 | 316 | 301 | 325 | 353 | 501 | 402 | 511 | 443 | 625 |
| Net income | 978 | 538 | 499 | 673 | 969 | 1,164 | 1,200 | 1,982 | 1,280 | 1,144 |
| Net income to common shareholders | 978 | 538 | 499 | 673 | 969 | 1,164 | 1,200 | 1,982 | 1,280 | 1,144 |
| Basic EPS | 3.36 | 1.83 | 1.70 | 2.30 | 3.31 | 3.96 | 3.96 | 6.47 | 4.17 | 3.74 |
| Diluted EPS | 3.36 | 1.83 | 1.70 | 2.30 | 3.31 | 3.96 | 3.96 | 6.45 | 4.16 | 3.73 |
| Average shares (basic) | 291 | 293 | 293 | 293 | 293 | 294 | 303 | 307 | 307 | 306 |
| Average shares (diluted) | 291 | 293 | 293 | 293 | 293 | 294 | 303 | 307 | 307 | 306 |
| Dividend per share | 1.49 | 1.44 | 1.19 | 1.12 | 1.35 | 1.34 | 1.20 | 1.17 | 1.06 | 0.96 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4,861 | 4,612 | 5,070 | 4,885 | 4,792 | 4,881 | 5,085 | 4,760 | 4,766 | 4,725 | 4,988 | 4,936 |
| Cost of revenue | 3,551 | 3,433 | 3,681 | 3,643 | 3,577 | 3,697 | 3,814 | 3,614 | 3,600 | 3,551 | 3,638 | 3,707 |
| Gross profit | 1,310 | 1,179 | 1,388 | 1,242 | 1,214 | 1,184 | 1,270 | 1,146 | 1,166 | 1,174 | 1,350 | 1,229 |
| Selling, general and administrative | 736 | 749 | 785 | 705 | 792 | 751 | 840 | 756 | 771 | 776 | 845 | 794 |
| Research and development | 39.6 | 38.3 | 38.6 | 37.7 | 38.1 | 43.5 | 50.1 | 40.0 | 45.6 | 47.8 | 66.0 | 53.0 |
| Operating income | 524 | 376 | 592 | 502 | 394 | 382 | 409 | 396 | 373 | 361 | 495 | 364 |
| EBIT | 524 | 376 | 592 | 502 | 394 | 382 | 409 | 396 | 373 | 361 | 495 | 364 |
| EBITDA | 879 | 728 | 780 | 854 | 750 | 758 | 610 | 762 | 745 | 749 | 709 | 751 |
| Interest expense | 97.6 | 93.3 | 99.0 | 93.1 | 96.6 | 95.7 | 101 | 99.1 | 103 | 104 | 111 | 114 |
| Pre-tax income | 383 | 208 | 508 | 403 | 351 | 251 | 179 | 381 | 339 | 158 | 343 | 236 |
| Income tax | 89.8 | 42.8 | 106 | 75.2 | 78.3 | 61.0 | 61.0 | 117 | 99.0 | 39.5 | 86.5 | 88.5 |
| Net income | 218 | 118 | 327 | 275 | 225 | 151 | 66.9 | 213 | 187 | 71.0 | 188 | 84.4 |
| Net income to common shareholders | 218 | 118 | 327 | 275 | 225 | 151 | 66.9 | 213 | 187 | 71.0 | 188 | 84.4 |
| Basic EPS | 0.81 | 0.43 | 1.14 | 0.94 | 0.77 | 0.52 | 0.23 | 0.73 | 0.64 | 0.24 | 0.64 | 0.29 |
| Diluted EPS | 0.81 | 0.43 | 1.14 | 0.94 | 0.77 | 0.52 | 0.22 | 0.73 | 0.64 | 0.24 | 0.64 | 0.29 |
| Average shares (basic) | 268 | 275 | 286 | 292 | 293 | 293 | 293 | 293 | 293 | 293 | 293 | 293 |
| Average shares (diluted) | 268 | 275 | 286 | 292 | 293 | 293 | 293 | 293 | 293 | 293 | 293 | 293 |
| Dividend per share | — | — | 1.49 | — | — | — | 1.44 | — | — | — | 1.19 | — |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 31,002 | 33,567 | 33,930 | 35,754 | 34,367 | 31,689 | 32,935 | 26,242 | 24,025 | 25,504 |
| Current assets | 7,898 | 7,923 | 8,701 | 8,203 | 7,967 | 7,275 | 7,165 | 7,847 | 6,374 | 6,884 |
| Cash and equivalents | 1,599 | 1,180 | 1,403 | 1,274 | 1,482 | 1,082 | 1,008 | 2,146 | 978 | 709 |
| Short-term investments | 141 | 163 | 154 | 188 | 159 | 179 | 156 | 120 | 15.5 | 266 |
| Receivables | 3,648 | 3,897 | 4,012 | 4,032 | 3,907 | 3,619 | 3,986 | 3,766 | 3,696 | 4,139 |
| Inventory | 2,141 | 2,068 | 2,179 | 2,296 | 2,038 | 1,895 | 1,663 | 1,467 | 1,291 | 1,337 |
| Net property, plant and equipment | 6,500 | 7,259 | 7,454 | 8,340 | 8,551 | 8,187 | 8,515 | 3,836 | 3,492 | 3,580 |
| Goodwill | 13,571 | 15,171 | 14,650 | 15,791 | 14,362 | 12,959 | 14,017 | 12,210 | 12,104 | 12,956 |
| Other intangible assets | 1,254 | 1,370 | 1,362 | 1,519 | 1,459 | 1,381 | 1,426 | 681 | 683 | 803 |
| Long-term investments | 1,056 | 1,125 | 1,080 | 1,199 | 787 | 761 | 697 | 650 | 647 | 598 |
| Current liabilities | 6,245 | 5,660 | 6,112 | 6,467 | 7,258 | 6,056 | 7,059 | 6,268 | 5,300 | 5,299 |
| Accounts payable | 820 | 956 | 839 | 893 | 819 | 795 | 756 | 703 | 631 | 840 |
| Long-term debt | 5,692 | 6,261 | 6,960 | 7,171 | 6,647 | 6,800 | 6,458 | 5,019 | 5,767 | 6,802 |
| Total debt | 10,779 | 10,977 | 11,594 | 12,544 | 12,064 | 12,301 | 12,611 | 6,152 | 6,679 | 7,559 |
| Total liabilities | 16,720 | 17,798 | 19,103 | 20,305 | 20,388 | 19,358 | 19,707 | 13,340 | 13,197 | 14,452 |
| Total equity (incl. minority) | 14,283 | 15,769 | 14,827 | 15,449 | 13,979 | 12,331 | 13,227 | 12,902 | 10,828 | 11,051 |
| Retained earnings | 12,208 | 11,266 | 10,922 | 10,712 | 10,826 | 10,255 | 9,455 | 8,832 | 7,137 | 6,086 |
| Minority interest | 973 | 1,192 | 1,206 | 1,460 | 1,280 | 1,116 | 1,269 | 1,144 | 1,008 | 1,073 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 31,293 | 31,468 | 31,002 | 30,887 | 31,291 | 32,735 | 33,567 | 32,511 | 33,896 | 34,336 | 33,930 | 35,635 |
| Current assets | 7,689 | 8,108 | 7,898 | 7,824 | 8,136 | 7,958 | 7,923 | 8,091 | 8,690 | 9,283 | 8,701 | 9,054 |
| Cash and equivalents | 1,061 | 1,239 | 1,599 | 1,256 | 1,715 | 1,071 | 1,180 | 1,371 | 1,090 | 1,148 | 1,403 | 1,553 |
| Short-term investments | — | 384 | 141 | 557 | 475 | 415 | 163 | — | — | — | 154 | — |
| Receivables | 3,465 | 3,715 | 3,648 | 3,275 | 3,231 | 3,592 | 3,897 | 3,279 | 4,062 | 4,050 | 4,012 | 3,714 |
| Inventory | 2,332 | 2,303 | 2,141 | 2,086 | 1,996 | 2,079 | 2,068 | 2,100 | 2,227 | 2,216 | 2,179 | 2,304 |
| Net property, plant and equipment | 6,430 | 6,443 | 6,500 | 6,398 | 6,499 | 6,981 | 7,259 | 6,977 | 7,262 | 7,306 | 7,454 | 7,885 |
| Goodwill | 13,968 | 13,846 | 13,571 | 13,585 | 13,621 | 14,645 | 15,171 | 14,227 | 14,807 | 14,676 | 14,650 | 15,407 |
| Other intangible assets | 1,280 | 1,257 | 1,254 | 1,250 | 1,253 | 1,326 | 1,370 | 1,308 | 1,355 | 1,360 | 1,362 | 1,407 |
| Long-term investments | 661 | 701 | 1,056 | 751 | 711 | 667 | 1,125 | 691 | 648 | 616 | 1,080 | 705 |
| Current liabilities | 7,178 | 6,730 | 6,245 | 5,759 | 5,661 | 5,447 | 5,660 | 5,889 | 5,936 | 6,204 | 6,112 | 6,619 |
| Accounts payable | 877 | 874 | 820 | 817 | 729 | 870 | 956 | 840 | 876 | 800 | 839 | 831 |
| Long-term debt | 5,825 | 5,741 | 5,692 | 6,323 | 6,327 | 6,149 | 6,261 | 6,234 | 6,854 | 7,017 | 6,960 | 7,264 |
| Total debt | 10,499 | 10,908 | 10,779 | 10,405 | 11,001 | 10,726 | 10,977 | 11,100 | 11,430 | 11,922 | — | — |
| Total liabilities | 17,762 | 17,263 | 16,720 | 16,979 | 16,964 | 17,230 | 17,798 | 17,720 | 18,709 | 19,204 | 19,103 | 20,200 |
| Total equity (incl. minority) | 13,531 | 14,205 | 14,283 | 13,908 | 14,327 | 15,505 | 15,769 | 14,791 | 15,187 | 15,132 | 14,827 | 15,435 |
| Retained earnings | 12,094 | 12,302 | 12,208 | 11,845 | 11,293 | 11,473 | 11,266 | 11,090 | 10,872 | 11,027 | 10,922 | 10,759 |
| Minority interest | 975 | 963 | 973 | 960 | 1,056 | 1,132 | 1,192 | 1,168 | 1,256 | 1,225 | 1,206 | 1,428 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2,681 | 2,386 | 2,629 | 2,167 | 2,489 | 4,233 | 2,567 | 2,062 | 2,192 | 1,932 |
| Depreciation and amortization | 1,400 | 1,483 | 1,613 | 1,720 | 1,585 | 1,587 | 1,553 | 725 | 735 | 702 |
| Capital expenditure | -915 | -699 | -685 | -724 | -854 | -1,052 | -1,125 | -1,057 | -944 | -931 |
| Investing cash flow | -723 | -84.9 | -544 | -735 | -1,196 | -1,335 | -3,286 | -245 | -992 | -1,246 |
| Financing cash flow | -1,403 | -2,569 | -1,859 | -1,617 | -1,024 | -2,664 | -467 | -682 | -799 | -520 |
| Dividends paid | -423 | -349 | -329 | -396 | -392 | -351 | -355 | -325 | -294 | -244 |
| Share repurchases | -585 | 0.0 | 0.0 | 0.0 | — | -366 | -600 | -37.2 | -57.9 | — |
| Debt issued | 1,779 | 146 | 483 | 1,799 | 3,048 | 2,916 | 4,861 | 1,481 | 1,306 | 1,044 |
| Debt repaid | -1,629 | -2,075 | -1,742 | -2,822 | -3,407 | -4,556 | -4,161 | -1,619 | -1,457 | -1,144 |
| Effect of exchange rates | -141 | 26.2 | -72.6 | -23.2 | 131 | -160 | 47.8 | 32.4 | -132 | 38.0 |
| Net change in cash | 414 | -242 | 153 | -208 | 400 | 73.8 | -1,138 | 1,168 | 269 | 204 |
| Free cash flow | 1,766 | 1,687 | 1,944 | 1,443 | 1,635 | — | — | — | — | — |
| Levered free cash flow | 1,556 | 2,031 | 1,312 | 1,023 | 1,697 | 2,356 | 1,166 | 723 | 1,132 | 1,484 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 860 | 227 | 1,002 | 742 | 775 | 163 | 832 | 985 | 442 | 127 | 719 | 760 |
| Depreciation and amortization | 357 | 354 | 297 | 358 | 362 | 383 | 339 | 372 | 384 | 388 | 346 | 393 |
| Capital expenditure | -240 | -190 | -423 | -192 | -154 | -146 | -241 | -165 | -159 | -134 | -250 | -137 |
| Investing cash flow | -271 | -169 | -418 | -54.0 | -142 | -108 | -119 | -220 | 323 | -68.4 | -96.5 | -151 |
| Financing cash flow | -770 | -436 | -208 | -1,135 | 79.2 | -139 | -965 | -477 | -837 | -290 | -746 | -412 |
| Dividends paid | -400 | — | 0.0 | 0.0 | -423 | — | 0.0 | 0.0 | -349 | — | — | — |
| Share repurchases | -145 | -347 | -434 | -151 | — | 0.0 | — | — | — | — | — | — |
| Debt issued | 447 | 173 | 498 | 72.7 | 1,102 | 106 | -76.3 | 5.3 | -79.7 | 297 | -105 | -161 |
| Debt repaid | -594 | -189 | -212 | -677 | -555 | -185 | -762 | -395 | -383 | -535 | -575 | -181 |
| Effect of exchange rates | 2.1 | 18.7 | -32.2 | -16.2 | -70.7 | -22.4 | 50.8 | -12.4 | -7.7 | -4.5 | -24.0 | 16.7 |
| Net change in cash | -178 | -360 | 343 | -464 | 641 | -107 | -202 | 275 | -80.1 | -235 | -147 | 213 |
| Free cash flow | 620 | 36.8 | 579 | 549 | 621 | 17.1 | 591 | 819 | 283 | -6.6 | 469 | 623 |
| Levered free cash flow | 1,136 | -79.2 | 118 | 848 | 786 | -195 | 710 | 1,003 | 762 | -444 | 567 | 243 |
Financial statements of similar companies
Companies in the group: same industry, similar size
